Aug 31, 2017 - Lilly (LLY) and Incyte announced that they will re-submit the new drug application (NDA) for their rheumatoid arthritis (RA) drug, baricitinib much faster than previously expected.
Aug 01, 2017 - Incyte Corp. (NASDAQ:INCY)Q2 2017 Earnings CallAugust 01, 2017 10:00 am ETExecutivesMichael Charles A. Booth - Incyte Corp.Hervé Hoppenot - Incyte Corp.Barry P. Flannelly - Incyte Corp.Steven H. Stein
Aug 15, 2017 - Gilead Sciences' CEO hints that buying a biotech with an oncology focus might not happen. Here's what this could mean for the big biotech.
Aug 31, 2017 - It's all about CAR-T stocks this week with Gilead (GILD) announcing its intention to acquire Kite Pharma for $11.9 billion and Novartis gaining FDA approval for the first CAR-T cell therapy.
Sep 28, 2017 - There have been some big winners over the past decade, but few have surpassed Priceline Group, Regeneron Pharmaceuticals, and Incyte.
Oct 25, 2017 - Even though the market slumped, these stocks gained ground. Find out why.
Nov 21, 2017 - Incyte Corp. (INCY) declined during the first 2 hours of trade Monday and slipped further going into the close. The stock finished with a loss of 6.52 at $98.95.
Jan 02, 2018 - RBC Capital Mkts issues rating change for INCY
Jan 08, 2018 - The following slide deck was published by Incyte Corporation in conjunction with this event.
Jan 12, 2018 - Bad news trumps good news for the biotech.